Magnus Jaderberg
Chief Medical Officer
Board of Director
Targovax
Norway
Biography
Experienced in all phases of clinical research including clinical pharmacology, dose finding, registration, post-launch product differentiation and surveillance. His immunotherapy expertise includes several compounds including Yervoy (ipilimumab). Prior to joining Oncos, Magnus held roles at national, European and global level at GSK, Pharmacia, Wyeth and most recently as Chief Medical Officer, Bristol Myers Squibb (Europe).
Research Interest
Pharmaceutical Medicine
